Similar articles

• Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.

  Platz KP, Tullius SG, Mueller AR, Schumacher G, Nüssler N, Neuhaus R, Bechstein WO, Lobeck H, Neuhaus P. Platz KP, et al. Transplant Proc. 1996 Dec;28(6):3183-4. Transplant Proc. 1996. PMID: 8962235 No abstract available.
• Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection.

  Kato T, Ruiz P, DeFaria W, Weppler D, Khan F, Pinna A, Nery J, Tzakis A. Kato T, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):396. doi: 10.1016/s0041-1345(98)01677-7. Transplant Proc. 1999. PMID: 10083158 Clinical Trial. No abstract available.
• Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.

  Klupp J, Glanemann M, Bechstein WO, Platz KP, Langrehr JM, Keck H, Settmacher U, Radtke C, Neuhaus R, Neuhaus P. Klupp J, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):1113-4. doi: 10.1016/s0041-1345(98)01925-3. Transplant Proc. 1999. PMID: 10083497 Clinical Trial. No abstract available.
• Neoral is superior to FK 506 in liver transplantation.

  Levy GA. Levy GA. Transplant Proc. 1998 Aug;30(5):1812-5. doi: 10.1016/s0041-1345(98)00442-4. Transplant Proc. 1998. PMID: 9723293 Review. No abstract available.
• Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis.

  Lan X, Liu MG, Chen HX, Liu HM, Zeng W, Wei D, Chen P. Lan X, et al. World J Gastroenterol. 2014 Sep 14;20(34):12330-40. doi: 10.3748/wjg.v20.i34.12330. World J Gastroenterol. 2014. PMID: 25232269 Free PMC article. Review.